Colorado Cancer Blogs
  • Home
  • Topics
    • Latest News
    • Research
    • Patient Care
    • Philanthropy
    • C3 Magazine
    • Honors
  • Cancer Types
    • bladder cancer
    • blood cancer
    • brain cancer
    • breast cancer
    • colorectal cancer
    • gynecologic cancer
    • head & neck cancer
    • lung cancer
    • pancreatic cancer
    • pediatric cancer
    • prostate cancer
    • sarcoma
    • skin cancer
  • Facebook
  • Twitter
Select Page
Study suggests PD-1 inhibitors against aggressive pediatric brain cancer subtype

Study suggests PD-1 inhibitors against aggressive pediatric brain cancer subtype

by Garth Sundem | Jan 29, 2018 | Latest News, Research

One type of immunotherapy removes a genetic blindfold that cancer uses to hide from the immune system. These “PD-1 inhibitors”, including drugs like pembrolizumab, nivolumab and atezolizumab, have proven useful and have even in some cases revolutionized the treatment...
Dasatinib excels in worldwide phase II trial against pediatric CML

Dasatinib excels in worldwide phase II trial against pediatric CML

by Garth Sundem | Jun 5, 2017 | Latest News, Research

In 2002, the FDA approved the drug imatinib as a first-line therapy for adults with chronic myeloid leukemia (CML) caused by the fusion gene BCR-ABL, known as the Philadelphia chromosome. The approval dramatically extended the lives of patients with the condition and,...
University of Colorado Cancer Center physicians join exclusive group

University of Colorado Cancer Center physicians join exclusive group

by Erika Matich | Mar 22, 2017 | Honors, Research

The pediatric neuro-oncology program at Children’s Hospital Colorado has been invited to join an exclusive group of physician/scientists dedicated to finding more effective, less toxic therapies for children with central nervous system tumors of the brain and spine....
Baseball, brain tumor and bravery: Matthew’s story

Baseball, brain tumor and bravery: Matthew’s story

by Taylor Abarca | Sep 12, 2016 | Patient Care

...
Study pinpoints driver, potential target in aggressive pediatric leukemia subtype

Study pinpoints driver, potential target in aggressive pediatric leukemia subtype

by Garth Sundem | Feb 18, 2016 | Latest News, Research

A University of Colorado Cancer Center study published today in the journal Cell Reports models Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL), discovering inactivation of the gene EZH2 as a driver and inroad to a potential therapeutic target in the...
« Older Entries

@CUCancerCenter on Twitter

  • @CUCancerCenter April 20, 2018

    Turning off autophagy helps chemotherapy stress #cancer cells to death ow.ly/L7y830j5fir https://t.co/Vy2jZhvJgL

  • @CUCancerCenter April 20, 2018

    #Adrenalcancer is rare. Unfortunately this means a lack of models to test new therapies. Until now.… twitter.com/i/web/status/9…

  • @CUCancerCenter April 20, 2018

    Did you know that the average age of #testicularcancer diagnosis is only 33? #TCisNoJoke #tscsm https://t.co/09VNWWyv6h

  • @CUCancerCenter April 20, 2018

    April is #TesticularCancerAwarenessMonth! #testicularcancer https://t.co/2p4vyjz0ja

  • @CUCancerCenter April 20, 2018

    My week on Twitter 🎉: 16 Mentions, 40.3K Mention Reach, 144 Likes, 64 Retweets, 112K Retweet Reach. See yours with… twitter.com/i/web/status/9…

  • @CUCancerCenter April 20, 2018

    CU researchers announced in early 2018 that they had established 2 #adrenalcancer cell lines and 2 animal models to… twitter.com/i/web/status/9…

  • @CUCancerCenter April 20, 2018

    New model, new drugs, and a "remarkable" response in #adrenalcancer ow.ly/M1vY30j5eCE https://t.co/gK8HOGiac0

  • @CUCancerCenter April 20, 2018

    #Cancer cells may develop resistance to treatment over time. CU study looks at how this happens in real time… twitter.com/i/web/status/9…

  • @CUCancerCenter April 20, 2018

    Tumors are always evolving. CU docs had the opportunity to watch how tumor cells develop resistance in real time.… twitter.com/i/web/status/9…

  • @CUCancerCenter April 20, 2018

    Considering getting a second opinion? https://t.co/giE0o1FknU

  • @CUCancerCenter April 20, 2018

    Exercise during #cancer treatment may be beneficial! https://t.co/0H0QRHpVj2

  • @CUCancerCenter April 20, 2018

    Here are 5 quick tips if you are cooking for someone battling #cancer! https://t.co/qnr9UsTcIr

Colorado Cancer Blogs

  • About Us
  • Comment Policy
  • Cover My News!

CU Cancer Center

  • Find a Doctor
  • Clinical Trials
  • Remote Second Opinion
  • Events

Subscribe to CU Cancer Blogs via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

  • Facebook
  • Twitter

Copyright © 2018 Colorado Cancer Blogs